Anebulo Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -1,290 | -1,593 | -2,760 |
EBIT | -1,340 | -3,258 | -2,763 |
Net Income | -1,349 | -1,653 | -2,717 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -2,052 | -1,497 | -1,813 |
Cash | 3,094 | 5,147 | 6,644 |
Basic Shares | 25,822 | 25,933 | 25,789 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -8,050 | -11,783 | 5 | -30,240 |
EBIT | -8,308 | -11,783 | -6,825 | -33,854 |
Net Income | -8,201 | -11,732 | -6,812 | -30,263 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,090 | -9,683 | -5,437 | -4,871 |
Cash | 3,094 | 11,247 | 14,548 | 19,985 |
Basic Shares | 25,822 | 25,074 | 23,344 | 23,344 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.08 |
2024-06-30 | -$0.05 |
2024-03-31 | -$0.06 |
2023-12-31 | -$0.11 |
